Reference : Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Scientific journals : Article
Human health sciences : Neurology
http://hdl.handle.net/2268/4971
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
English
Sandor, P. S. [> > > >]
Di Clemente, L. [> > > >]
Coppola, G. [> > > >]
Saenger, U. [> > > >]
Fumal, Arnaud mailto [Centre Hospitalier Universitaire de Liège - CHU > > Neurologie CHR >]
Magis, Delphine mailto [Centre Hospitalier Universitaire de Liège - CHU > > Neurologie Sart Tilman >]
Seidel, Laurence mailto [Université de Liège - ULg > Département des sciences de la santé publique > Informatique médicale et biostatistique >]
Agosti, R. M. [> > > >]
Schoenen, Jean mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Neuro-anatomie]
22-Feb-2005
Neurology
Lippincott Williams & Wilkins
64
4
713-715
Yes (verified by ORBi)
International
0028-3878
Philadelphia
[en] Riboflavin, which improves energy metabolism similarly to coenzyme Q10 (CoQ10), is effective in migraine prophylaxis. We compared CoQ10 (3 x 100 mg/day) and placebo in 42 migraine patients in a double-blind, randomized, placebo-controlled trial. CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat: 3). CoQ10 is efficacious and well tolerated.
Researchers ; Professionals
http://hdl.handle.net/2268/4971

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
q10.pdfPublisher postprint225.11 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.